The BCR-ABL1 gene encodes a constitutively active tyrosine kinase, BCR::ABL, which plays a central role in the pathogenesis of CML by promoting uncontrolled cell proliferation and inhibiting apoptosis [2]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.